IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omthera Pharmaceuticals Inc

CUSIP: 682CVR998 | 3 institutional holders

Quarters

Q1 2019Q2 2018Q1 2018Q1 2014Q4 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2019

Tiaa Cref Investment Management LLC21,835
0.0% of portfolio›$13
StyleTurnoverLocationFiled
Tiaa Cref Investment Management LLC
21,835$130.0%N/AN/ANew York, NY2019-05-14